477 results on '"Mendizabal, Manuel"'
Search Results
2. SAT-129 Sub-optimal global public health policies and strategies to combat hepatocellular carcinoma
3. Drug-induced Liver Injury in Latin America: 10-year Experience of the Latin American DILI (LATINDILI) Network
4. Evolving portal hypertension through Baveno VII recommendations
5. Regional Differences in Clinical Presentation and Prognosis of Patients With Post–Sustained Virologic Response Hepatocellular Carcinoma
6. Norfloxacin prophylaxis effect on multidrug resistance in patients with cirrhosis and bacterial infections
7. Liver transplantation in Latin America: reality and challenges
8. Nitrofurantoin-induced liver injury: long-term follow-up in two prospective DILI registries
9. Genetic Ancestry, Race, and Severity of Acutely Decompensated Cirrhosis in Latin America
10. MELD 3.0 adequately predicts mortality and renal replacement therapy requirements in patients with alcohol-associated hepatitis
11. Clinical and microbiological characteristics of bacterial infections in patients with cirrhosis. A prospective cohort study from Argentina and Uruguay
12. Liver decompensation is a frequent cause of treatment discontinuation and prognostic factor in intermediate-advanced HCC
13. Inpatient Hepatology Consultation: A Practical Approach for Clinicians
14. Efficacy and safety of direct-acting antiviral agents for HCV in mild-to-moderate chronic kidney disease
15. Have CFTR modulators changed the need for liver and lung transplantation among patients with cystic fibrosis? An analysis of the UNOS database.
16. Herbal and Dietary Supplements-Induced Liver Injury in Latin America: Experience From the LATINDILI Network
17. Comparison of different prognostic scores for patients with cirrhosis hospitalized with SARS-CoV-2 infection
18. ‘Real-life’ experience with direct-acting antiviral agents for HCV after kidney transplant
19. Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide study
20. Prospective Latin American cohort evaluating outcomes of patients with COVID-19 and abnormal liver tests on admission
21. Outbreak of hepatitis A in a post-vaccination era: High rate of co-infection with sexually transmitted diseases
22. LI-RADS 4 or 5 categorization may not be clinically relevant for decision-making processes: A prospective cohort study
23. Disease Progression in Patients With Hepatitis C Virus Infection Treated With Direct-Acting Antiviral Agents
24. A Latin American survey on demographic aspects of hospitalized, decompensated cirrhotic patients and the resources for their management
25. Hepatitis E infection is an infrequent cause of acute hepatitis in the metropolitan area of Buenos Aires
26. LBP-012 Epidemiological trends and clinical impact of multidrug-resistant bacterial infections in patients with cirrhosis across Latin America: results from the ACLARA study
27. LBO-004 Excess waitlist mortality and survival benefit of liver transplantation for patients with severe acute-on-chronic liver failure: Interim results of the CHANCE study
28. An artificial intelligence-generated model predicts 90-day survival in alcohol-associated hepatitis: A global cohort study
29. Serious liver injury induced by Nimesulide: an international collaborative study
30. The genetic variability of hepatitis B virus subgenotype F1b precore/core gene is related to the outcome of the acute infection
31. 348.3: Prevalence of Chagas Disease in Deceased Donors From Argentina
32. 248.1: Hepatitis B virus Status of Organ Donors in Argentina
33. 211.4: Characterization and Utilization of HCV-positive Donors in Argentina
34. A different gut microbiome linked to inflammation found in cirrhotic patients with and without hepatocellular carcinoma
35. Liver transplantation in adults with acute liver failure: Outcomes from the Argentinean Transplant Registry
36. O-27 IMPACT OF HBV GENOTYPE F IN THE DIAGNOSIS AND EVOLUTION OF PATIENTS WITH HBEAG-NEGATIVE CHRONIC HBV INFECTION
37. OP-5 ACUTE-ON-CHRONIC LIVER FAILURE (ACLF) CRITERIA IN ALCOHOL-ASSOCIATED HEPATITIS: IMPLICATIONS FOR LIVER TRANSPLANTATION
38. OP- 10 - NON-STEROIDAL ANTI-INFLAMMATORY DRUGS: A COMPARATIVE ANALYSIS BETWEEN THE SPANISH AND LATINDILI NETWORKS
39. OP-3 ASSESSING TREATMENT ELIGIBILITY EXPANSION UNDER THE 2024 WHO GUIDELINES FOR CHRONIC HEPATITIS B
40. O2- CHARACTERIZATION OF STEATOTIC LIVER DISEASE AND THE ROLE OF GENETIC BACKGROUND IN LATIN AMERICA
41. O-1 SIMULTANEOUS LIVER-KIDNEY TRANSPLANTATION OUTCOMES IN LATIN AMERICA
42. O3- RECOMPENSATION IN PATIENTS WITH CIRRHOSIS PRIOR TO FIRST LINE SYSTEMIC THERAPY IS ASSOCIATED WITH SIMILAR SURVIVAL OUTCOMES COMPARED TO COMPENSATED CIRRHOSIS
43. P-117 CONTINUOUS INTRAVENOUS TACROLIMUS FOR LIVER TRANSPLANT RECIPIENTS: IMPLEMENTATION STRATEGY AND CLINICAL OUTCOMES
44. P-84 HAVE CFTR MODULATORS CHANGED THE NEED FOR LIVER TRANSPLANTATION AMONG PATIENTS WITH CYSTIC FIBROSIS? AN ANALYSIS OF THE UNOS DATABASE
45. P-57 SUSCEPTIBILITY PATTERNS AND EMPIRICAL ANTIBIOTIC GUIDANCE FOR URINARY TRACT INFECTIONS IN PATIENTS WITH CIRRHOSIS
46. P-53 IMMUNE-MEDIATED ADVERSE EVENTS FOLLOWING ATEZOLIZUMAB PLUS BEVACIZUMAB IS ASSOCIATED WITH DECREASED SURVIVAL IN PATIENTS WITH CIRRHOSIS
47. P-43 PROGNOSTIC MODELS AFTER TRANSARTERIAL CHEMOEMBOLIZATION IN A LATIN AMERICAN PROSPECTIVE COHORT STUDY
48. P-32 ACCESSIBILITY TO SEQUENTIAL SYSTEMIC TREATMENT AFTER TACE: IMPACT ON SURVIVAL IN A LATIN AMERICAN PROSPECTIVE COHORT
49. Recommendations on the Diagnosis and Initial Management of Acute Variceal Bleeding and Hepatorenal Syndrome in Patients with Cirrhosis
50. Hepatitis C and hepatocellular carcinoma in Latin America: Elimination as a path to cancer prevention
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.